Insider Trading & Ownership - Elefant Dov

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Elefant Dov
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-28
Purchase
2020-12-28
4:30 pm
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
7,407$1.35$9,99911,755
(Direct)
View
2020-06-05
Purchase
2020-06-08
4:08 pm
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
4,348$1.145$4,9786,522
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-02
4:43 pm
N/A
2034-02-01
FEMASYS INCFEMYElefant Dov
Chief Financial Officer
84,000$084,000
(Direct)
View
2023-07-03
Option Award
2023-07-03
6:00 pm
N/A
2033-07-03
FEMASYS INCFEMYElefant Dov
Chief Financial Officer
309,900$0309,900
(Direct)
View
2022-02-28
Option Award
2022-03-01
4:38 pm
N/A
2032-02-28
FEMASYS INCFEMYElefant Dov
Chief Financial Officer
100,000$0100,000
(Direct)
View
2022-01-25
Option Award
2022-01-27
4:06 pm
N/A
2032-01-25
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
422,000$0422,000
(Direct)
View
2021-03-04
Option Award
2021-03-05
5:46 pm
N/A
2031-03-04
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
430,000$0430,000
(Direct)
View
2020-02-03
Option Award(A)
2020-03-05
4:02 pm
N/A
2030-02-03
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
10,000$010,000
(Direct)
View
2020-02-03
Option Award
2020-02-04
4:02 pm
N/A
N/A
Cellectar Biosciences Inc.CLRBElefant Dov
Chief Financial Officer
10,000$2.7110,000
(Direct)
View
(A) Indicate amendment filing.